Hong Kong Pharma Digital Technology Holdings Limited
HKPD
$1.07
$0.0050.47%
NASDAQ
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 58.24% | 58.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 58.24% | 58.24% | |||
| Cost of Revenue | 61.91% | 61.91% | |||
| Gross Profit | 42.63% | 42.63% | |||
| SG&A Expenses | -11.42% | -11.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -144.44% | -144.44% | |||
| Total Operating Expenses | 50.92% | 50.92% | |||
| Operating Income | 202.06% | 202.06% | |||
| Income Before Tax | 256.97% | 256.97% | |||
| Income Tax Expenses | 496.83% | 496.83% | |||
| Earnings from Continuing Operations | 232.77% | 232.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 232.77% | 232.77% | |||
| EBIT | 202.06% | 202.06% | |||
| EBITDA | 185.55% | 185.55% | |||
| EPS Basic | 127.47% | 127.47% | |||
| Normalized Basic EPS | 144.80% | 144.80% | |||
| EPS Diluted | 130.00% | 130.00% | |||
| Normalized Diluted EPS | 144.80% | 144.80% | |||
| Average Basic Shares Outstanding | 46.13% | 46.13% | |||
| Average Diluted Shares Outstanding | 46.13% | 46.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||